SLC(SH:603648) Sou Hu Cai Jing·2025-04-27 11:25Core Viewpoint - In 2024, Changlian Co., Ltd. reported a total operating revenue of 1.519 billion yuan, a year-on-year decrease of 6.90%, and a net profit attributable to shareholders of 131 million yuan, down 14.51%, indicating overall weak performance despite growth in the medical and consumer goods sectors [1][4][6]. Revenue and Profit Decline - The total operating revenue for 2024 was 1.519 billion yuan, down from 1.632 billion yuan in 2023, reflecting a decline of 6.90% [4][5]. - The net profit attributable to shareholders was 131 million yuan, a decrease of 14.51% year-on-year [4][5]. - In the fourth quarter, revenue and net profit saw significant declines of 41.1% and 44.0% year-on-year, respectively, indicating substantial operational pressure at year-end [4][6]. Sector Performance - The medical and consumer goods sectors showed notable growth, contributing positively to the overall performance [4][6]. - Despite the growth in these sectors, the overall business structure requires further optimization due to poor performance in other areas such as high-tech electronics, medical devices, and machinery [5][6]. Information Technology and Digitalization - The company has made significant investments in information technology and digitalization, enhancing service capabilities and expanding its national network with 36 subsidiaries [6]. - However, the short-term effects of these investments have been limited, as evidenced by the decline in both operating revenue and net profit in 2024 [6].